Yes, providers often reduce or gradually increase the dose to balance results with comfort and safety
While you might notice a slight reduction in hunger, significant appetite changes are uncommon during this period
Inflammation and immune-metabolic signaling Chronic inflammation can affect vascular health, metabolic function, mood, pain, sleep, and brain aging
The medication is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 0.25 mg weekly and gradually escalated over 16 weeks (0.250.51.01.72.4 mg
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test evaluates predispositions in GLP-1 pathway genes (GIPR), metabolic genes (FTO, MC4R), and related variants that may provide context for individual tolerability